Go to Top

Tag Archives

Tag Archives: Protalix BioTherapeutics

Protalix BioTherapeutics (PLX): Offer of Potential All-Cash Acquisition

Protalix BioTherapeutics, Inc. (PLX) is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins through its ProCellEx® plant cell-based protein expression system. Using ProCellEx, Protalix is focused on the development and commercialization of a proprietary pipeline of novel and biosimilar proteins that target large, established pharmaceutical markets and that rely …Read More